A detailed history of Israel Englander (Millennium Management LLC) transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,777,601 shares of MCRB stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,777,601
Previous 1,027,552 72.99%
Holding current value
$1.46 Million
Previous $791,000 61.69%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.56 - $1.19 $420,027 - $892,558
750,049 Added 72.99%
1,777,601 $1.28 Million
Q1 2024

May 15, 2024

SELL
$0.75 - $1.56 $897,392 - $1.87 Million
-1,196,523 Reduced 53.8%
1,027,552 $791,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.15 $431,669 - $997,946
464,161 Added 26.37%
2,224,075 $3.11 Million
Q2 2023

Aug 14, 2023

BUY
$4.67 - $6.55 $6.31 Million - $8.85 Million
1,351,434 Added 330.84%
1,759,914 $8.43 Million
Q1 2023

May 15, 2023

BUY
$4.95 - $6.09 $1 Million - $1.24 Million
203,008 Added 98.8%
408,480 $2.32 Million
Q4 2022

Feb 14, 2023

BUY
$5.09 - $9.05 $1.05 Million - $1.86 Million
205,472 New
205,472 $1.15 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.62 $1.36 Million - $3.85 Million
504,624 Added 85.63%
1,093,910 $3.75 Million
Q1 2022

May 16, 2022

SELL
$6.3 - $8.84 $4.25 Million - $5.97 Million
-675,200 Reduced 53.4%
589,286 $4.2 Million
Q4 2021

Feb 14, 2022

BUY
$6.02 - $11.43 $5.88 Million - $11.2 Million
976,368 Added 338.88%
1,264,486 $10.5 Million
Q3 2021

Nov 15, 2021

BUY
$5.46 - $22.6 $439,917 - $1.82 Million
80,571 Added 38.82%
288,118 $2.01 Million
Q2 2021

Aug 16, 2021

SELL
$18.46 - $24.36 $1.1 Million - $1.45 Million
-59,574 Reduced 22.3%
207,547 $4.95 Million
Q1 2021

May 17, 2021

SELL
$17.66 - $28.92 $876,430 - $1.44 Million
-49,628 Reduced 15.67%
267,121 $5.5 Million
Q4 2020

Feb 16, 2021

BUY
$23.25 - $37.73 $810,820 - $1.32 Million
34,874 Added 12.37%
316,749 $7.76 Million
Q3 2020

Nov 16, 2020

SELL
$3.74 - $28.74 $330,544 - $2.54 Million
-88,381 Reduced 23.87%
281,875 $7.98 Million
Q2 2020

Aug 14, 2020

BUY
$3.04 - $6.2 $1.13 Million - $2.3 Million
370,256 New
370,256 $1.76 Million
Q3 2019

Nov 14, 2019

SELL
$2.29 - $4.16 $737,050 - $1.34 Million
-321,856 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$2.28 - $7.35 $634,555 - $2.05 Million
278,314 Added 639.19%
321,856 $1.04 Million
Q2 2019

Aug 14, 2019

SELL
$2.28 - $7.35 $564,865 - $1.82 Million
-247,748 Reduced 85.05%
43,542 $2.17 Million
Q1 2019

May 14, 2019

BUY
$4.83 - $7.21 $1.41 Million - $2.1 Million
291,290 New
291,290 $2 Million
Q4 2018

Feb 14, 2019

SELL
$4.52 - $8.88 $66,683 - $131,006
-14,753 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$7.33 - $9.23 $1.15 Million - $1.45 Million
-157,420 Reduced 91.43%
14,753 $112,000
Q2 2018

Aug 14, 2018

BUY
$6.91 - $9.55 $596,664 - $824,623
86,348 Added 100.61%
172,173 $1.48 Million
Q1 2018

May 15, 2018

SELL
$7.34 - $11.16 $1.54 Million - $2.34 Million
-209,850 Reduced 70.97%
85,825 $630,000
Q4 2017

Feb 14, 2018

BUY
$9.15 - $12.64 $777,164 - $1.07 Million
84,936 Added 40.3%
295,675 $3 Million
Q3 2017

Nov 14, 2017

BUY
$12.81 - $16.85 $2.7 Million - $3.55 Million
210,739
210,739 $3.38 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.